TACROLIMUS (TACROLIMUS MONOHYDRATE) — all Canadian products
7 DINs
5 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is TACROLIMUS (TACROLIMUS MONOHYDRATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02459477 | APO-TACROLIMUS | APOTEX INC | Capsule (Immediate-Release) | Oral | TACROLIMUS (TACROLIMUS MONOHYDRATE) 1 MG | Approved | |
| 02459485 | APO-TACROLIMUS | APOTEX INC | Capsule (Immediate-Release) | Oral | TACROLIMUS (TACROLIMUS MONOHYDRATE) 5 MG | Approved | |
| 02416832 | SANDOZ TACROLIMUS | SANDOZ CANADA INCORPORATED | Capsule (Immediate-Release) | Oral | TACROLIMUS (TACROLIMUS MONOHYDRATE) 5 MG | Marketed | |
| 02416816 | SANDOZ TACROLIMUS | SANDOZ CANADA INCORPORATED | Capsule (Immediate-Release) | Oral | TACROLIMUS (TACROLIMUS MONOHYDRATE) 0.5 MG | Marketed | |
| 02416824 | SANDOZ TACROLIMUS | SANDOZ CANADA INCORPORATED | Capsule (Immediate-Release) | Oral | TACROLIMUS (TACROLIMUS MONOHYDRATE) 1 MG | Marketed | |
| 02460254 | JAMP-TACROLIMUS | JAMP PHARMA CORPORATION | Capsule (Immediate-Release) | Oral | TACROLIMUS (TACROLIMUS MONOHYDRATE) 5 MG | Cancelled Pre Market | |
| 02460246 | JAMP-TACROLIMUS | JAMP PHARMA CORPORATION | Capsule (Immediate-Release) | Oral | TACROLIMUS (TACROLIMUS MONOHYDRATE) 1 MG | Cancelled Pre Market |
Browse other molecules: